Skip to main content
Clinical Trials/ACTRN12611000766910
ACTRN12611000766910
Recruiting
Phase 2

Randomised blinded control pilot trial investigating the effect of N-acetylcysteine in the treatment of acute decompensated heart failure

Alfred Health0 sites70 target enrollmentJuly 21, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Alfred Health
Enrollment
70
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Hospital admission with acute decompensated HF including congestion (or) hypotension (or) worsening renal function (or) other end organ dysfunction.
  • \-NYHA Class III or IV
  • \-LVEF \< 40%

Exclusion Criteria

  • Age \< 18, and \>75
  • \-LVAD or ECMO in situ or likely requirement for LVAD/ECMO within 24 hrs
  • \-endotracheal intubation/ventilation
  • \-cardiac or other solid organ transplantation
  • \-STEMI at presentation
  • \-Allergy to n\-acetylcysteine
  • \- pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials